SlideShare a Scribd company logo
5/B-2 Phase - 5 Hayatabad Peshawar Pakistan
healthcare@rmi.edu.pk
Dr Shah Taj Khan
M.B.B.S,DCP,FCPS
Consultant Hematologist.
Rehman Medical Institute, Peshawar.
Pakistan
STUDY
Glucose 6 Phosphate Dehydrogenase
(G6PD) EnzymeDeficiency in jaundiced
infants in Khyber Pakhtoonkhwa
Shahtaj Khan1, Awal Mir2, Inam3, Baber Rehman4, Fazl e Raziq5
Khawaja Tassawor.Nadia Altaf.
INTRODUCTION
• G6PD deficiency is X-linked recessive hereditary disease
characterized by abnormally low levels of glucose-6-phosphate-
dehydrogenase
MODE OF INHERITANCE IN
G6PD
What Happens In G6PD Deficiency?
CLINICAL MANISFESTATIONS
• Neonatal Jaundice
• Acute vs Chronic Hemolysis
Infection,oxidant drugs, fava beans, chemical agents
• Keep in mind other blood cells require G6pd as well
• Phagocytosis could be impaired
Peripheral Blood Findings
Screening Tests For G6PD
deficiency
Fluorescent Spot
Test
Methemoglobin
reduction Test
DEFINITIVE DIAGNOSIS IS DONE ON G6PD DEFICIENCY
Global Distribution Of G6pd
Deficiency
G6PD deficiency variant proportion in
Asia
CLASSIFICATION OF G6PD VARIANTS
Prevalence of G6PD deficiency in Pakistan
Moiz B. A review of G6PD deficiency in Pakistani perspective. J Pak Med
Assoc. 2013Apr;63(4):501-3.
Epidemiology And Malaria
• 50 % reduction in severe malaria in African children
• In female heterozygotes there are more malarial parasites in
G6pd replete cells as compared to deficient
• Invasion appears to be similar but growth is retarded in G6pd
cells
• Possible mechanism is oxidant stress leading to cell death or
membrane damage leading to phagocytosis
OBJECTIVE
• The aim of this study was to evaluate the prevalence of G6PD
deficiency by G6PD quantitative method in jaundiced infants
coming from different districts of Khyber Pakhtoon Khwa (KPK)
MATERIALS AND METHODS
• Study design:
Descriptive cross sectional study
• Study setting and duration:
Rehman Medical Institute Hayatabad Peshawar- Febuary 2015-
September 2015 (8 months)
• Sampling technique:
Non-consecutive probability sampling
MATERIALS AND METHODS
• Inclusion/ Exclusion criteria:
Infants of <1 year age having hyperbilirubinemia
MATERIALS AND METHODS
• Data collection:
• By aseptic technique 4 ml blood was collected from all infants, 2 ml
blood in EDTA tube (Purple Top) for G6PD quantitative enzyme assay
and 2 ml in non anticoagulated tube ( Red Top) to determine serum
bilirubin profile.
• Serum bilirubin profile was determined by Diazo reaction method using
Architect plus ci8200 (Abbott, USA).
• G6PD quantitative assay was measured by ultraviolet kinetic method
(Trinity biotech kit, USA).
MATERIALS AND METHODS
• Data Analysis:
The data was collected and analyzed in SPSS-20.
RESULTS
Prevalence of G6PD deficiency anemia in
different gender neonates
Serum Bilirubin Comparative Analysis
Medicines Associated With Hemolysis in
G6PD deficiency patients
COMPARITIVE STUDIES
STUDY COUNTRY NO OF
PATIENTS
RESULT
Pahlavanzadeh M
et all 2013.
IRAN 105 18.1%
29.4% boys
7.4% girls
Yang Q, Wang Q
et all 2014
CHINA 2500 2.68%
3.2% boys
2.03% girls
CONCLUSION
• 11% of infants presenting with jaundice were G6PD deficient.
• Quantitative G6PD levels should be done at least prior to anti
malarial therapy in every infant.
POINT TO BE FOCUSSED…
As the study was conducted in our area, which is
endemic for malaria and poverty leads to frequent
episodes of infection, certain drugs can cause fatal
hemolysis. So as per WHO protocol our population
needs routine screening for G6PD deficiency.
THANK YOU

More Related Content

Similar to shahtaj-khan-hayatabad-medical-complex-pakistan.pptx

Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDayDr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Canadian Organization for Rare Disorders
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
HariharanK48
 
Prostate carcinoma- tumour markers
Prostate  carcinoma- tumour markersProstate  carcinoma- tumour markers
Prostate carcinoma- tumour markers
GovtRoyapettahHospit
 
midodrine vs albumin to prevent paracentesis induced circulatory dysfunction
midodrine vs albumin to prevent paracentesis induced circulatory dysfunctionmidodrine vs albumin to prevent paracentesis induced circulatory dysfunction
midodrine vs albumin to prevent paracentesis induced circulatory dysfunction
ameenmda
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
Eugene Elwell
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
ORALFLUIDLEADTEST
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
Hussain Karimi
 
malaria etiology , management, treatment
malaria etiology , management, treatmentmalaria etiology , management, treatment
malaria etiology , management, treatment
nishmithrai80
 
A1 c versus glucose testing 19 5-2014 departement conference
A1 c versus glucose testing 19 5-2014 departement conferenceA1 c versus glucose testing 19 5-2014 departement conference
A1 c versus glucose testing 19 5-2014 departement conference
Moustafa Rezk
 
serum Bilirubin and some Hematological parameters in Patients with Presenile ...
serum Bilirubin and some Hematological parameters in Patients with Presenile ...serum Bilirubin and some Hematological parameters in Patients with Presenile ...
serum Bilirubin and some Hematological parameters in Patients with Presenile ...
MatiaAhmed
 
Pharmacogenetic testing in clinical settings
Pharmacogenetic testing in clinical settings Pharmacogenetic testing in clinical settings
Pharmacogenetic testing in clinical settings
DRMOHITKHER
 
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activitiesMechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
PhinC Development
 
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
 
cord blood albumin assesment.pptx
cord blood albumin assesment.pptxcord blood albumin assesment.pptx
cord blood albumin assesment.pptx
JitenLad2
 
komal's proposal.pptx
komal's proposal.pptxkomal's proposal.pptx
komal's proposal.pptx
KOMALPATEL365046
 
Glucose 6-phosphate dehydrogenase deficiency
Glucose 6-phosphate dehydrogenase deficiencyGlucose 6-phosphate dehydrogenase deficiency
Glucose 6-phosphate dehydrogenase deficiency
Alade Olubunmi
 
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of NewbornEvaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
iosrphr_editor
 
Sickle cell disease: Newer treatments. Will India be Sickle free by 2047?
Sickle cell disease: Newer treatments.Will India be Sickle free by 2047?Sickle cell disease: Newer treatments.Will India be Sickle free by 2047?
Sickle cell disease: Newer treatments. Will India be Sickle free by 2047?
Pritish Chandra Patra
 
atrial fibrillation
atrial fibrillation atrial fibrillation
atrial fibrillation
auriom
 
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesTurning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Merck Life Sciences
 

Similar to shahtaj-khan-hayatabad-medical-complex-pakistan.pptx (20)

Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDayDr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
 
Prostate carcinoma- tumour markers
Prostate  carcinoma- tumour markersProstate  carcinoma- tumour markers
Prostate carcinoma- tumour markers
 
midodrine vs albumin to prevent paracentesis induced circulatory dysfunction
midodrine vs albumin to prevent paracentesis induced circulatory dysfunctionmidodrine vs albumin to prevent paracentesis induced circulatory dysfunction
midodrine vs albumin to prevent paracentesis induced circulatory dysfunction
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
 
malaria etiology , management, treatment
malaria etiology , management, treatmentmalaria etiology , management, treatment
malaria etiology , management, treatment
 
A1 c versus glucose testing 19 5-2014 departement conference
A1 c versus glucose testing 19 5-2014 departement conferenceA1 c versus glucose testing 19 5-2014 departement conference
A1 c versus glucose testing 19 5-2014 departement conference
 
serum Bilirubin and some Hematological parameters in Patients with Presenile ...
serum Bilirubin and some Hematological parameters in Patients with Presenile ...serum Bilirubin and some Hematological parameters in Patients with Presenile ...
serum Bilirubin and some Hematological parameters in Patients with Presenile ...
 
Pharmacogenetic testing in clinical settings
Pharmacogenetic testing in clinical settings Pharmacogenetic testing in clinical settings
Pharmacogenetic testing in clinical settings
 
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activitiesMechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
 
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
10. Dr. Alex Kudrin - Medicines and Healthcare Products Regulatory Agency (UK)
 
cord blood albumin assesment.pptx
cord blood albumin assesment.pptxcord blood albumin assesment.pptx
cord blood albumin assesment.pptx
 
komal's proposal.pptx
komal's proposal.pptxkomal's proposal.pptx
komal's proposal.pptx
 
Glucose 6-phosphate dehydrogenase deficiency
Glucose 6-phosphate dehydrogenase deficiencyGlucose 6-phosphate dehydrogenase deficiency
Glucose 6-phosphate dehydrogenase deficiency
 
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of NewbornEvaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
Evaluation the efficacy of IVIgG in treatment of Hemolytic Disease of Newborn
 
Sickle cell disease: Newer treatments. Will India be Sickle free by 2047?
Sickle cell disease: Newer treatments.Will India be Sickle free by 2047?Sickle cell disease: Newer treatments.Will India be Sickle free by 2047?
Sickle cell disease: Newer treatments. Will India be Sickle free by 2047?
 
atrial fibrillation
atrial fibrillation atrial fibrillation
atrial fibrillation
 
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesTurning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene Therapies
 

Recently uploaded

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 

Recently uploaded (20)

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 

shahtaj-khan-hayatabad-medical-complex-pakistan.pptx

  • 1. 5/B-2 Phase - 5 Hayatabad Peshawar Pakistan healthcare@rmi.edu.pk Dr Shah Taj Khan M.B.B.S,DCP,FCPS Consultant Hematologist. Rehman Medical Institute, Peshawar. Pakistan
  • 2. STUDY Glucose 6 Phosphate Dehydrogenase (G6PD) EnzymeDeficiency in jaundiced infants in Khyber Pakhtoonkhwa Shahtaj Khan1, Awal Mir2, Inam3, Baber Rehman4, Fazl e Raziq5 Khawaja Tassawor.Nadia Altaf.
  • 3. INTRODUCTION • G6PD deficiency is X-linked recessive hereditary disease characterized by abnormally low levels of glucose-6-phosphate- dehydrogenase
  • 5. What Happens In G6PD Deficiency?
  • 6. CLINICAL MANISFESTATIONS • Neonatal Jaundice • Acute vs Chronic Hemolysis Infection,oxidant drugs, fava beans, chemical agents • Keep in mind other blood cells require G6pd as well • Phagocytosis could be impaired
  • 8. Screening Tests For G6PD deficiency Fluorescent Spot Test Methemoglobin reduction Test
  • 9. DEFINITIVE DIAGNOSIS IS DONE ON G6PD DEFICIENCY
  • 10. Global Distribution Of G6pd Deficiency
  • 11. G6PD deficiency variant proportion in Asia
  • 13. Prevalence of G6PD deficiency in Pakistan Moiz B. A review of G6PD deficiency in Pakistani perspective. J Pak Med Assoc. 2013Apr;63(4):501-3.
  • 14. Epidemiology And Malaria • 50 % reduction in severe malaria in African children • In female heterozygotes there are more malarial parasites in G6pd replete cells as compared to deficient • Invasion appears to be similar but growth is retarded in G6pd cells • Possible mechanism is oxidant stress leading to cell death or membrane damage leading to phagocytosis
  • 15. OBJECTIVE • The aim of this study was to evaluate the prevalence of G6PD deficiency by G6PD quantitative method in jaundiced infants coming from different districts of Khyber Pakhtoon Khwa (KPK)
  • 16. MATERIALS AND METHODS • Study design: Descriptive cross sectional study • Study setting and duration: Rehman Medical Institute Hayatabad Peshawar- Febuary 2015- September 2015 (8 months) • Sampling technique: Non-consecutive probability sampling
  • 17. MATERIALS AND METHODS • Inclusion/ Exclusion criteria: Infants of <1 year age having hyperbilirubinemia
  • 18. MATERIALS AND METHODS • Data collection: • By aseptic technique 4 ml blood was collected from all infants, 2 ml blood in EDTA tube (Purple Top) for G6PD quantitative enzyme assay and 2 ml in non anticoagulated tube ( Red Top) to determine serum bilirubin profile. • Serum bilirubin profile was determined by Diazo reaction method using Architect plus ci8200 (Abbott, USA). • G6PD quantitative assay was measured by ultraviolet kinetic method (Trinity biotech kit, USA).
  • 19. MATERIALS AND METHODS • Data Analysis: The data was collected and analyzed in SPSS-20.
  • 21. Prevalence of G6PD deficiency anemia in different gender neonates
  • 23. Medicines Associated With Hemolysis in G6PD deficiency patients
  • 24. COMPARITIVE STUDIES STUDY COUNTRY NO OF PATIENTS RESULT Pahlavanzadeh M et all 2013. IRAN 105 18.1% 29.4% boys 7.4% girls Yang Q, Wang Q et all 2014 CHINA 2500 2.68% 3.2% boys 2.03% girls
  • 25. CONCLUSION • 11% of infants presenting with jaundice were G6PD deficient. • Quantitative G6PD levels should be done at least prior to anti malarial therapy in every infant.
  • 26. POINT TO BE FOCUSSED… As the study was conducted in our area, which is endemic for malaria and poverty leads to frequent episodes of infection, certain drugs can cause fatal hemolysis. So as per WHO protocol our population needs routine screening for G6PD deficiency.